1. Home
  2. ALDX vs FRGE Comparison

ALDX vs FRGE Comparison

Compare ALDX & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • FRGE
  • Stock Information
  • Founded
  • ALDX 2004
  • FRGE 2014
  • Country
  • ALDX United States
  • FRGE United States
  • Employees
  • ALDX N/A
  • FRGE N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • ALDX Health Care
  • FRGE Technology
  • Exchange
  • ALDX Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • ALDX 133.7M
  • FRGE 159.4M
  • IPO Year
  • ALDX 2014
  • FRGE N/A
  • Fundamental
  • Price
  • ALDX $2.17
  • FRGE $13.45
  • Analyst Decision
  • ALDX Strong Buy
  • FRGE Buy
  • Analyst Count
  • ALDX 2
  • FRGE 3
  • Target Price
  • ALDX $9.50
  • FRGE $52.50
  • AVG Volume (30 Days)
  • ALDX 1.5M
  • FRGE 248.9K
  • Earning Date
  • ALDX 05-20-2025
  • FRGE 05-07-2025
  • Dividend Yield
  • ALDX N/A
  • FRGE N/A
  • EPS Growth
  • ALDX N/A
  • FRGE N/A
  • EPS
  • ALDX N/A
  • FRGE N/A
  • Revenue
  • ALDX N/A
  • FRGE $85,383,000.00
  • Revenue This Year
  • ALDX N/A
  • FRGE $20.86
  • Revenue Next Year
  • ALDX N/A
  • FRGE $28.07
  • P/E Ratio
  • ALDX N/A
  • FRGE N/A
  • Revenue Growth
  • ALDX N/A
  • FRGE 16.04
  • 52 Week Low
  • ALDX $1.14
  • FRGE $6.60
  • 52 Week High
  • ALDX $7.20
  • FRGE $29.85
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 36.53
  • FRGE 56.83
  • Support Level
  • ALDX $1.90
  • FRGE $11.88
  • Resistance Level
  • ALDX $2.89
  • FRGE $14.53
  • Average True Range (ATR)
  • ALDX 0.22
  • FRGE 1.20
  • MACD
  • ALDX 0.09
  • FRGE 0.02
  • Stochastic Oscillator
  • ALDX 33.46
  • FRGE 56.12

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: